Rights and permissions
About this article
Cite this article
Evidence favours regular β2-agonist use. Inpharma Wkly. 984, 20 (1995). https://doi.org/10.2165/00128413-199509840-00041
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199509840-00041